Webinar :Join us on Jan 21, 22 and 23, 2021 at the ANYBODY CAN TRADE 360° LIVE virtual event. Register Now!

Hold Aurobindo Pharma; target of Rs 710: Sharekhan

Sharekhan recommended Hold rating on Aurobindo Pharma with a target price of Rs 710 in its research report dated August 08, 2019.

August 12, 2019 / 05:11 PM IST
  • bselive
  • nselive
Todays L/H

Sharekhan's research report on Aurobindo Pharma

Q1 numbers were strong; new products, better product mix and operational efficiencies led to robust profitability. Gross debt reduced by ~ Rs 1,084 crore to Rs. 5883.2 crore; net debt fell by Rs. 915 crore to Rs. 4,094 crore. Regulatory hurdles at various plants would weigh on stock until successful resolution.


We maintain a Hold rating with an unchanged PT of Rs. 710. We expect company to report sales and profit CAGRs of 29% and 22%,
respectively, in the next two years.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Broker Research
first published: Aug 12, 2019 05:11 pm

stay updated

Get Daily News on your Browser